Patents by Inventor Qinghong Han

Qinghong Han has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240115673
    Abstract: A composition and method for treating cancer in a subject in need thereof. The composition includes recombinant-methioninase-producing bacterial strains that upon oral administration can release recombinant-methioninase in the gut of the subject. The bacterial strains include Escherichia coli bacteria comprising the cloned rMETase gene from Pseudomonas putida using plasmid pATG3131, such as Escherichia coli JM109 strain. The bacteria can be incorporated in the microbiome of the subject and release the recombinant-methioninase.
    Type: Application
    Filed: October 6, 2023
    Publication date: April 11, 2024
    Inventors: Yutaro Kubota, Qinghong Han, Robert Hoffman
  • Patent number: 11873519
    Abstract: A composition and method for reversing or preventing age-related metabolic and tissue degenerative changes in individuals. The method includes administering, orally, an effective amount of a first composition having methioninase enzyme. The method further includes administering, by a route other than the oral route, such as a parenteral route, an effective amount of a second composition having methioninase enzyme. The method further includes the steps of orally and/or parentally administering pyridoxal-L-phosphate.
    Type: Grant
    Filed: May 25, 2022
    Date of Patent: January 16, 2024
    Inventors: Qinghong Han, Robert M Hoffman
  • Publication number: 20220340891
    Abstract: A composition and method for lowing serum and plasma levels of methionine by oral administration. The composition includes a recombinant methioninase enzyme and a cofactor (pyridoxal-L-phosphate). Methods of use describe methods for treatment of cancer, including malignant melanoma, by oral administration of the methioninase composition. Methods for chronic suppressive therapy of melanoma and other cancers are described. Because reduction of plasma methionine levels is effective in treating other conditions, including diabetes and conditions associated with aging, the use of the methods described herein includes treatment of these and other conditions.
    Type: Application
    Filed: May 25, 2022
    Publication date: October 27, 2022
    Inventors: Qinghong Han, Robert M Hoffman
  • Patent number: 11376702
    Abstract: The present disclosure discloses an integrated rotary cutting tool manufacturing device and method, the integrated rotary cutting tool manufacturing device comprises a workpiece transfer device, a machine body, a feeding device, grinding devices and a discharge device. The grinding devices comprise a rough grinding device used for carrying out primary grinding on a vertically arranged workpiece and a fine grinding device used for carrying out secondary grinding on the vertically arranged workpiece. The integrated rotary cutting tool manufacturing device is adopted by the rotary cutting tool manufacturing method. The device according to the present disclosure is compact in structure, high in machining efficiency and precision, and low in costs, the maximum values, the minimum values and the average values of the roundness and the concentricity of machined micro drill bits are closer to the standard values, and the stabilization process capability indexes of the roundness.
    Type: Grant
    Filed: August 7, 2018
    Date of Patent: July 5, 2022
    Assignee: SHENZHEN JINZHOU PRECISION TECHNOLOGY CORPORATION
    Inventors: Qinghong Han, Jian Zhu, Junli Liu
  • Patent number: 11371036
    Abstract: A composition and method for lowing serum and plasma levels of methionine by oral administration. The composition includes a recombinant methioninase enzyme and a cofactor (pyridoxal-L-phosphate). Methods of use describe methods for treatment of cancer, including malignant melanoma, by oral administration of the methioninase composition. Methods for chronic suppressive therapy of melanoma and other cancers are described. Because reduction of plasma methionine levels is effective in treating other conditions, including diabetes and conditions associated with aging, the use of the methods described herein includes treatment of these and other conditions.
    Type: Grant
    Filed: April 8, 2021
    Date of Patent: June 28, 2022
    Inventors: Qinghong Han, Robert M Hoffman
  • Publication number: 20210330767
    Abstract: Oral composition and a method for the treatment of coronaviruses infections in humans and animals. The method includes the steps of administering orally a methionine cleaving-enzyme; administering orally or parentally a protease inhibitor; and orally administering pyridoxal-L-phosphate in a fluid.
    Type: Application
    Filed: July 1, 2021
    Publication date: October 28, 2021
    Inventors: Qinghong Han, Robert Hoffman
  • Publication number: 20210254040
    Abstract: A composition and method for lowing serum and plasma levels of methionine by oral administration. The composition includes a recombinant methioninase enzyme and a cofactor (pyridoxal-L-phosphate). Methods of use describe methods for treatment of cancer, including malignant melanoma, by oral administration of the methioninase composition. Methods for chronic suppressive therapy of melanoma and other cancers are described. Because reduction of plasma methionine levels is effective in treating other conditions, including diabetes and conditions associated with aging, the use of the methods described herein includes treatment of these and other conditions.
    Type: Application
    Filed: April 8, 2021
    Publication date: August 19, 2021
    Applicant: AntiCancer Inc.
    Inventors: Qinghong Han, Robert M. Hoffman
  • Patent number: 11001826
    Abstract: A composition and method for lowing serum and plasma levels of methionine by oral administration. The composition includes a recombinant methioninase enzyme and a cofactor (pyridoxal-L-phosphate). Methods of use describe methods for treatment of cancer, including malignant melanoma, by oral administration of the methioninase composition. Methods for chronic suppressive therapy of melanoma and other cancers are described. Because reduction of plasma methionine levels is effective in treating other conditions, including diabetes and conditions associated with aging, the use of the methods described herein includes treatment of these and other conditions.
    Type: Grant
    Filed: October 19, 2018
    Date of Patent: May 11, 2021
    Assignee: ANTICANCER, INC.
    Inventors: Qinghong Han, Shukuan Li, Yuying Tan, Kei Kawaguchi, Robert M. Hoffman, Sant Chawla
  • Publication number: 20190153421
    Abstract: A composition and method for lowing serum and plasma levels of methionine by oral administration. The composition includes a recombinant methioninase enzyme and a cofactor (pyridoxal-L-phosphate). Methods of use describe methods for treatment of cancer, including malignant melanoma, by oral administration of the methioninase composition. Methods for chronic suppressive therapy of melanoma and other cancers are described. Because reduction of plasma methionine levels is effective in treating other conditions, including diabetes and conditions associated with aging, the use of the methods described herein includes treatment of these and other conditions.
    Type: Application
    Filed: October 19, 2018
    Publication date: May 23, 2019
    Inventors: Qinghong Han, Shukuan Li, Yuying Tan, Kei Kawaguchi, Robert M. Hoffman, Sant Chawla
  • Publication number: 20180339388
    Abstract: The present disclosure discloses an integrated rotary cutting tool manufacturing device and method, the integrated rotary cutting tool manufacturing device comprises a workpiece transfer device, a machine body, a feeding device, grinding devices and a discharge device. The grinding devices comprise a rough grinding device used for carrying out primary grinding on a vertically arranged workpiece and a fine grinding device used for carrying out secondary grinding on the vertically arranged workpiece. The integrated rotary cutting tool manufacturing device is adopted by the rotary cutting tool manufacturing method. The device according to the present disclosure is compact in structure, high in machining efficiency and precision, and low in costs, the maximum values, the minimum values and the average values of the roundness and the concentricity of machined micro drill bits are closer to the standard values, and the stabilization process capability indexes of the roundness.
    Type: Application
    Filed: August 7, 2018
    Publication date: November 29, 2018
    Inventors: Qinghong Han, Jian Zhu, Junli Liu
  • Patent number: 7264819
    Abstract: Infection by P. carinii can be treated by administering methioninase optionally in combination with additional therapeutic agents, such as antibiotics.
    Type: Grant
    Filed: June 22, 2004
    Date of Patent: September 4, 2007
    Assignee: AntiCancer, Inc.
    Inventors: Yuying Tan, Zhijian Yang, Xinghua Sun, Shukuan Li, Qinghong Han, Mingxu Xu
  • Patent number: 6927038
    Abstract: A method to determine a total cysteine in biological fluids utilizes similarly treated portions of the fluid with a homocysteinase and a non-specific desulfurase.
    Type: Grant
    Filed: November 20, 2002
    Date of Patent: August 9, 2005
    Assignee: AntiCancer, Inc.
    Inventors: Qinghong Han, Mingxu Xu, Li Tang, Yuying Tan
  • Publication number: 20050031606
    Abstract: Infection by P. carinii can be treated by administering methioninase optionally in combination with additional therapeutic agents, such as antibiotics.
    Type: Application
    Filed: June 22, 2004
    Publication date: February 10, 2005
    Inventors: Yuying Tan, Zhijian Yang, Xinghua Sun, Shukuan Li, Qinghong Han, Mingxu Xu
  • Publication number: 20040121421
    Abstract: A homocysteine assay that can be performed on very small quantities of blood is described. This assay is suitable for screening, including screening newborns for homocysteinuria.
    Type: Application
    Filed: September 3, 2003
    Publication date: June 24, 2004
    Inventors: Qinghong Han, Yuying Tan
  • Patent number: 6713273
    Abstract: The invention provides novel methods relating to SAM detection and production as well as a novel SAHH enzymatic activity for use in such methods. Additional methods, compositions, and kits relating to the novel SAHH are also provided.
    Type: Grant
    Filed: January 12, 2001
    Date of Patent: March 30, 2004
    Assignee: AntiCancer, Inc.
    Inventors: Mingxu Xu, Qinghong Han
  • Patent number: 6653092
    Abstract: A method to detect and measure the concentration of hydrogen peroxide comprises adding reagents consisting essentially of peroxidase and a dialkyl phenylenediamine and detecting any color generated by the interaction of hydrogen peroxide with these reagents.
    Type: Grant
    Filed: October 30, 2001
    Date of Patent: November 25, 2003
    Assignee: AntiCancer, Inc.
    Inventors: Qinghong Han, Li Tang, Mingxu Xu, Yuying Tan, Shigeo Yagi
  • Publication number: 20030162239
    Abstract: A method to determine a total cysteine in biological fluids utilizes similarly treated portions of the fluid with a homocysteinase and a non-specific desulfurase.
    Type: Application
    Filed: November 20, 2002
    Publication date: August 28, 2003
    Inventors: Qinghong Han, Mingxu Xu, Li Tang, Yuying Tan
  • Publication number: 20020119491
    Abstract: The invention provides novel methods relating to SAM detection and production as well as a novel SAHH enzymatic activity for use in such methods. Additional methods, compositions, and kits relating to the novel SAHH are also provided.
    Type: Application
    Filed: January 12, 2001
    Publication date: August 29, 2002
    Inventors: Mingxu Xu, Qinghong Han
  • Patent number: 6426194
    Abstract: Enzymatic methods to determine the concentration of pyridoxal 5′-phosphate (PLP) in biological fluids are described. The methods of the invention are useful to assess risk for cardiovascular disease. The assay can be a homogeneous assay using the ability of PLP to function as a co-enzyme for homocysteinase and related enzymes and measuring the products of the reaction preferably spectrophotometrically. The invention also includes improvements in sensitivity of assays for measuring hydrogen sulfide production by measuring fluorescence as opposed to absorbance of the oxidized product of H2S with N,N-dialkyl p-phenylene diamine.
    Type: Grant
    Filed: February 1, 2000
    Date of Patent: July 30, 2002
    Assignee: AntiCancer, Inc.
    Inventors: Mingxu Xu, Qinghong Han, Yuying Tan
  • Publication number: 20020037545
    Abstract: A method to assess the level of folate in a biological sample comprises.
    Type: Application
    Filed: October 30, 2001
    Publication date: March 28, 2002
    Inventors: Qinghong Han, Li Tang, Mingxu Xu, Yuying Tan, Shigeo Yagi